EMA
approval
· 2026-03-19
EMA Authorised: Aerius (desloratadine) — Organon N.V.
Summary
The European Medicines Agency has authorised Aerius (desloratadine), a non-sedating antihistamine for allergic rhinitis (perennial and seasonal) and urticaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal. MAH: Organon N.V.. Decision date: 26/02/2026